| 18/12/2023 | Share Purchase Plan Offer |
| 18/12/2023 | Cleansing Notice – SPP |
| 11/12/2023 | Investor Webinar |
| 11/12/2023 | Appendix 3B |
| 11/12/2023 | Notice of EGM |
| 11/12/2023 | Share Purchase Plan |
| 11/12/2023 | Minimum Holding Buy-Back |
| 11/12/2023 | Delisting Announcement |
| 07/12/2023 | Trading Halt |
| 17/11/2023 | Results of Meeting AGM 2023 |
| 17/11/2023 | CEO Presentation to AGM November 2023 |
| 17/11/2023 | Chairman’s address to Shareholders 2023 AGM |
| 17/11/2023 | App 3Z BS |
| 27/10/2023 | Corporate Governance Statement |
| 27/10/2023 | Appendix 4G |
| 24/10/2023 | Rhinomed operational review |
| 20/10/2023 | Update on AGM and impending Board change |
| 19/10/2023 | Rhinoswab Program Update |
| 18/10/2023 | Annual Report to Shareholders 2023 |
| 18/10/2023 | Notice of Annual General Meeting & Proxy Form 2023 |
| 16/10/2023 | Retirement of Director |
| 07/09/2023 | Appendix 3Y JMcB |
| 08/08/2023 | Patent award in USA |
| 18/05/2023 | Change in substantial holding WG |
| 04/05/2023 | App 3Y MJ |
| 31/03/2023 | Change in substantial holding WG |
| 27/01/2023 | Canadian Market Update |
| 24/01/2023 | Executive Remuneration Review |